Compound Summary
Compound Information
ETHAMIVAN
Compound Name: | ETHAMIVAN |
Compound CID: | 9363 |
Synonyms: | ETHAMIVAN Etamivan Vanillic acid diethylamide 304-84-7 Vandid More... |
Iupac Name: | N,N-diethyl-4-hydroxy-3-methoxybenzamide |
InChI: | InChI=1S/C12H17NO3/c1-4-13(5-2)12(15)9-6-7-10(14)11(8-9)16-3/h6-8,14H,4-5H2,1-3H3 |
InChIKey: | BQJODPIMMWWMFC-UHFFFAOYSA-N |
Canonical Smiles: | CCN(CC)C(=O)C1=CC(=C(C=C1)O)OC |
Isomeric Smiles: | CCN(CC)C(=O)C1=CC(=C(C=C1)O)OC |
Molecular Weight: | 223.27 |
Molecular Formula: | C12H17NO3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ETHAMIVAN
Molecular Weight: | 223.27 |
Molecular Formula: | C12H17NO3 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 16 |
Complexity: | 228 |
Synonyms
ETHAMIVAN
| ETHAMIVAN | ETHAMIVAN |
|---|---|
ETHAMIVAN |
Etamivan |
Vanillic acid diethylamide |
304-84-7 |
Vandid |
Analepticon |
Etamivanum |
Emivan |
Cardiovanil |
Corivanil |
Diethamivan |
Simaron |
Diethylvanillamide |
Ventilone |
Romecor |
Sevanil |
N,N-Diethylvanillamide |
N,N-Diethyl-4-hydroxy-3-methoxybenzamide |
Cardiovamil |
Sevinal |
Benzamide, N,N-diethyl-4-hydroxy-3-methoxy- |
Diethylamide de vanillique |
Vanillic acid N,N-diethylamide |
Vanillinsaeure-diaethylamid |
Vanillamide, N,N-diethyl- |
3-Methoxy-4-hydroxybenzoic acid diethylamide |
UNII-M44O63YPV9 |
MLS000028445 |
N,N-diethyl-4-hydroxy-3-methoxy-benzamide |
M44O63YPV9 |
Ethamivan;N,N-Diethylvanillamide |
NSC406087 |
NSC-406087 |
NCGC00015397-02 |
NCGC00015397-06 |
CAS-304-84-7 |
SMR000058359 |
DSSTox_CID_3007 |
DSSTox_RID_76829 |
DSSTox_GSID_23007 |
Etamivanum INN-Latin |
N,N-diethyl(4-hydroxy-3-methoxyphenyl)carboxamide |
SR-01000003047 |
Ethamivan USAN:USP |
Vanillinsaeure-diaethylamid German |
EINECS 206-157-3 |
NSC 406087 |
BRN 2694478 |
Clairvan |
AI3-20163 |
2xdl |
Etamivan INN |
Prestwick_909 |
Vandid (TN) |
Vanillamide,N-diethyl- |
N, N-Diethylvanillamide |
Opera_ID_522 |
Ethamivan (USAN/INN) |
Prestwick0_000500 |
Prestwick1_000500 |
Prestwick2_000500 |
Prestwick3_000500 |
Lopac-E-0137 |
Lopac0_000459 |
BSPBio_000399 |
ZINC266 |
4-10-00-01481 (Beilstein Handbook Reference) |
MLS001146918 |
SCHEMBL119823 |
SPBio_002320 |
BPBio1_000439 |
CHEMBL1229908 |
DTXSID3023007 |
vanillic acid N,N-diethyl amide |
CHEBI:92675 |
HMS1569D21 |
HMS2094A19 |
HMS2096D21 |
HMS2231D12 |
HMS3261K20 |
HMS3369J14 |
HMS3713D21 |
Pharmakon1600-01505994 |
HY-B1096 |
Tox21_110135 |
Tox21_110136 |
Tox21_500459 |
WLN: 2N2 & VR DQ CO1 |
2787AH |
BDBM50482752 |
NSC759302 |
SBB057405 |
AKOS003382844 |
Tox21_110135_1 |
2-METHYL-4-DIETHYLAMIDE-PHENOL |
CCG-204551 |
CS-4684 |
DB08989 |
LP00459 |
MCULE-4849532738 |
NSC-759302 |
SDCCGSBI-0050444.P003 |
NCGC00015397-01 |
NCGC00015397-03 |
NCGC00015397-04 |
NCGC00015397-05 |
NCGC00015397-07 |
NCGC00015397-08 |
NCGC00015397-10 |
NCGC00015397-15 |
NCGC00023704-03 |
NCGC00023704-04 |
NCGC00261144-01 |
BP-12587 |
Benzamide,N-diethyl-4-hydroxy-3-methoxy- |
SBI-0050444.P002 |
DB-047788 |
EU-0100459 |
N,N-Diethyl-4-hydroxy-3-methoxybenzamide # |
ST45025689 |
N,N-diethyl-4-hydroxy-3-(methyloxy)benzamide |
D04080 |
E 0137 |
J-017977 |
Q5402414 |
SR-01000003047-2 |
SR-01000003047-5 |
BRD-K38055836-001-03-9 |
2DL |
Experimental Data
ETHAMIVAN
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 21 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
ETHAMIVAN
Statistics Data
ETHAMIVAN
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 21 | 1 | 1 |
Statistics Data Visualization
ETHAMIVAN
